凝血分析仪市场规模、份额和成长分析（按产品、测试、技术、最终用户和地区）- 产业预测 2025-2032

2023 年全球凝血分析仪市场规模价值 42 亿美元，预计将从 2024 年的 44.4 亿美元成长到 2032 年的 69.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.8%。

受血液凝固障碍和心血管疾病发病率上升的推动，全球凝血分析仪市场正在经历强劲增长。这些分析仪在抗凝血治疗的有效监测和管理中发挥关键作用。推动市场扩张的关键因素包括技术进步以实现更快、更准确的结果以及医疗保健支出的增加。此外，随着领先公司推出旨在改善患者治疗效果的创新解决方案，对便携式和易于使用的设备的需求也日益增加。然而，挑战依然存在，包括定价压力和严格的法律规范。虽然北美和欧洲继续占据市场占有率的首位，但亚太地区已成为一个有希望的成长地区。整体而言，由于对高效凝血监测解决方案的需求不断增长，市场前景依然乐观。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管分析

凝血分析仪市场规模（依产品及复合年增长率） (2025-2032)

• 市场概况
• 临床检测与分析设备
  • 耗材
  • 试剂
  • 标准控制校准
  • 系统
  • 自动化系统
  • 半自动系统
  • 手动系统
• 就地检验和分析设备

凝血分析仪市场规模（依测试类型和复合年增长率） （2025-2032）

• 市场概况
• 凝血酶原时间检测
• D-二聚体检测
• 纤维蛋白原检测
• 活化凝血时间检测
• 活化部份凝血活酵素时间试验
• 血小板功能检查
• 抗XA因子检测
• ACT 的肝素和鱼精蛋白剂量反应测试
• 其他血液凝固检验

凝血分析仪市场规模（依技术及复合年增长率） (2025-2032)

• 市场概况
• 光学技术
• 机械工业
• 电化学技术
• 其他技术

凝血分析仪市场规模（依最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院
• 临床实验室
• 其他最终用户

凝血分析仪市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Roche Diagnostics（Switzerland）
• Siemens Healthineers（Germany）
• Abbott Laboratories（United States）
• Sysmex Corporation（Japan）
• Thermo Fisher Scientific（United States）
• Instrumentation Laboratory（IL）（United States）
• Helena Laboratories（United States）
• Nihon Kohden（Japan）
• Diagnostica Stago（France）
• Werfen（Spain）
• Grifols（Spain）
• International Technidyne Corporation（ITC）（United States）
• HemoSonics（United States）
• Randox Laboratories（United Kingdom）
• Helena Point of Care（United States）
• Medtronic（Ireland）
• EKF Diagnostics（United Kingdom）

结论和建议

Global Coagulation Analyzer Market size was valued at USD 4.2 billion in 2023 and is poised to grow from USD 4.44 billion in 2024 to USD 6.98 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The global coagulation analyzer market is experiencing robust growth, propelled by the increasing prevalence of clotting disorders and cardiovascular diseases. These analyzers play a vital role in the effective monitoring and management of anticoagulant therapies. Key factors fueling market expansion include technological advancements that facilitate faster, more precise results and rising healthcare expenditures. The demand for portable, user-friendly devices is also on the rise, as major players introduce innovative solutions aimed at improving patient outcomes. However, challenges such as pricing pressures and stringent regulatory frameworks persist. While North America and Europe continue to lead in market share, the Asia-Pacific region is emerging as a promising growth area. Overall, the market outlook remains positive, driven by the escalating need for efficient coagulation monitoring solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Coagulation Analyzer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coagulation Analyzer Market Segments Analysis

Global Coagulation Analyzer Market is segmented by Product, Test, Technology, End User and region. Based on Product, the market is segmented into Clinical Laboratory Analyzers and Point-Of-Care Testing Analyzers. Based on Test, the market is segmented into Prothrombin Time Testing, D-Dimer Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, Platelet Function Tests, Anti-Factor XA Tests, Heparin & Protamine Dose Response Tests for Act and Other Coagulation Tests. Based on Technology, the market is segmented into Optical Technology, Mechanical Technology, Electrochemical Technology and Other Technologies. Based on End User, the market is segmented into Hospitals, Clinical Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Coagulation Analyzer Market

The aging global population is contributing to a heightened prevalence of several medical conditions, particularly coagulation disorders. As the number of elderly individuals rises, there will be a corresponding surge in the need for coagulation analyzers that facilitate the diagnosis and management of clotting issues like deep vein thrombosis (DVT) and hemophilia. This increased demand is driven by the urgent requirement for efficient monitoring and treatment solutions to address these disorders effectively, which positions the global coagulation analyzer market for significant growth in response to the healthcare needs of an aging demographic.

Restraints in the Global Coagulation Analyzer Market

The Global Coagulation Analyzer market faces significant restraints due to the high costs associated with purchasing and maintaining these devices. Smaller healthcare facilities and those in resource-limited areas often struggle with the substantial initial investment required along with ongoing expenses for maintenance, reagents, and regular calibration. These financial challenges can create barriers to acquiring advanced coagulation analyzers, limiting access to essential diagnostic tools and potentially impacting the quality of patient care in these regions. As a result, the economic constraints hinder the widespread adoption and utilization of coagulation analyzers worldwide.

Market Trends of the Global Coagulation Analyzer Market

The Global Coagulation Analyzer market is experiencing a significant shift due to technological advancements and increased automation, which are revolutionizing laboratory practices. Manufacturers are prioritizing the development of analyzers characterized by superior accuracy, efficiency, and intuitive user interfaces. Innovations such as barcode scanning, automated sample loading, and seamless integration with laboratory information systems are gaining traction, ultimately streamlining testing processes and mitigating human errors. This trend not only enhances laboratory productivity but also aligns with the growing demand for rapid and reliable diagnostic solutions in healthcare settings. As a result, the market is poised for robust growth as facilities adopt these advanced technologies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Analysis

Global Coagulation Analyzer Market Size by Product & CAGR (2025-2032)

• Market Overview
• Clinical Laboratory Analyzers
  • Consumables
  • Reagents
  • Standards, Controls, and Calibrations
  • Systems
  • Automated systems
  • Semi-automated systems
  • Manual systems
• Point-Of-Care Testing Analyzers

Global Coagulation Analyzer Market Size by Test & CAGR (2025-2032)

• Market Overview
• Prothrombin Time Testing
• D-Dimer Testing
• Fibrinogen Testing
• Activated Clotting Time Testing
• Activated Partial Thromboplastin Time Testing
• Platelet Function Tests
• Anti-Factor XA Tests
• Heparin & Protamine Dose Response Tests for Act
• Other Coagulation Tests

Global Coagulation Analyzer Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Optical Technology
• Mechanical Technology
• Electrochemical Technology
• Other Technologies

Global Coagulation Analyzer Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinical Laboratories
• Other End Users

Global Coagulation Analyzer Market Size & CAGR (2025-2032)

• North America (Product, Test, Technology, End User)
  • US
  • Canada
• Europe (Product, Test, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Test, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Test, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Test, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory (IL) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagnostica Stago (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Technidyne Corporation (ITC) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HemoSonics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Point of Care (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations